Processa Pharmaceuticals, Inc. Payments to Acquire Software
Processa Pharmaceuticals, Inc. (PCSA) reported Payments to Acquire Software of $20.50 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-06.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireSoftware · last filed 2020-03-06
- Processa Pharmaceuticals, Inc. payments to acquire software for the quarter ending 2018-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. payments to acquire software for fiscal 2018 was $20.50K.
| Period end | Payments to Acquire Software 3 month | Payments to Acquire Software 9 month | Payments to Acquire Software 12 month |
|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $20.50K 10-K · filed 2020-03-06 | |
| 2018-09-30 | $20.50K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |